Activest Wealth Management’s Oruka Therapeutics ORKA Stock Holding History

Activest Wealth Management’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.8K	Hold	166	–	–	﹤0.01%	526
2026 Q2	$15.8K	Hold	166	–	–	﹤0.01%	488
2026 Q1	$8.14K	Hold	166	–	–	﹤0.01%	726
2025 Q4	$5.03K	Hold	166	–	–	﹤0.01%	766
2025 Q3	$3.19K	Hold	166	–	–	﹤0.01%	718
2025 Q2	$1.86K	Hold	166	–	–	﹤0.01%	696
2025 Q1	$1.7K	Hold	166	–	–	﹤0.01%	686
2024 Q4	$3.22K	Hold	166	–	–	﹤0.01%	402
2024 Q3	$4.07K	Sell	166 -1	-0.6%	-$35	﹤0.01%	379
2024 Q2	$7.66K	Buy	+167	New	+$6.66K	﹤0.01%	316

Other funds holding ORKA

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return

Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return

Activest Wealth Management's ORKA Position: Q3 2026 in Review

Activest Wealth Management held its Oruka Therapeutics (ORKA) position steady in Q3 2026 at 166 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #526.

Activest Wealth Management first reported a position in ORKA in Q2 2024 and has held it in 10 quarters since. The position peaked at $15.8K in Q2 2026. 53 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

Activest Wealth Management held 166 shares of Oruka Therapeutics worth $13.8K as of Q3 2026.
Activest Wealth Management left its Oruka Therapeutics share count unchanged in Q3 2026.
Oruka Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #526 holding.
Activest Wealth Management first reported a position in Oruka Therapeutics in Q2 2024 and has held it in 10 quarters since.
Activest Wealth Management's Oruka Therapeutics position peaked at $15.8K in Q2 2026.
53 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.